MLYS · Mineralys Therapeutics, Inc.
Market Cap
$2.49B
Shares
88.41M
The company's filings as submitted to the SEC's EDGAR system — 10-K, 10-Q, 8-K, proxy statements and more — listed most recent first.
| Type | Filing Date | Period | Open |
|---|---|---|---|
| 8-K | 2026-08-11 | 2026-08-05 | |
| 10-Q | 2026-08-11 | 2026-06-30 | |
| Investor Event Transcript | 2026-06-09 | 2026-06-30 | |
| 8-K | 2026-06-03 | 2026-06-02 | |
| 8-K | 2026-06-03 | — | |
| Investor Event Transcript | 2026-06-03 | 2026-06-30 | |
| 8-K | 2026-05-22 | 2026-05-21 | |
| 10-Q | 2026-05-06 | 2026-03-31 | |
| 8-K | 2026-05-06 | — | |
| DEF 14A | 2026-04-08 | 2026-05-21 | |
| 8-K | 2026-03-12 | — | |
| 10-K | 2026-03-12 | 2025-12-31 | |
| 8-K | 2026-03-09 | 2026-03-06 | |
| 8-K | 2026-01-06 | — | |
| 10-Q | 2025-11-10 | 2025-09-30 | |
| 8-K | 2025-11-10 | — | |
| 8-K | 2025-09-03 | 2025-09-02 | |
| 8-K | 2025-09-02 | — | |
| 8-K | 2025-08-12 | — | |
| 10-Q | 2025-08-12 | 2025-06-30 | |
| 8-K | 2025-06-17 | — | |
| 8-K | 2025-05-22 | — | |
| 10-Q | 2025-05-12 | 2025-03-31 | |
| 8-K | 2025-05-12 | — | |
| DEF 14A | 2025-04-09 | 2025-05-22 | |
| 8-K | 2025-03-31 | 2025-03-29 | |
| 8-K | 2025-03-12 | 2025-03-11 | |
| 8-K | 2025-03-10 | — | |
| 8-K | 2025-02-12 | — | |
| 10-K | 2025-02-12 | 2024-12-31 | |
| 8-K | 2025-02-04 | — | |
| 8-K | 2025-01-08 | — | |
| 8-K | 2024-11-12 | 2024-11-11 | |
| 10-Q | 2024-11-12 | 2024-09-30 | |
| 8-K | 2024-10-30 | — | |
| 8-K | 2024-09-25 | — | |
| 10-Q | 2024-08-13 | 2024-06-30 | |
| 8-K | 2024-08-13 | — | |
| 8-K | 2024-06-14 | 2024-06-13 | |
| 8-K | 2024-06-10 | — | |
| 8-K | 2024-05-31 | — | |
| 8-K | 2024-05-22 | — | |
| 10-Q | 2024-05-09 | 2024-03-31 | |
| 8-K | 2024-05-09 | — | |
| DEF 14A | 2024-04-09 | — | |
| 8-K | 2024-04-04 | 2024-03-29 | |
| 10-K | 2024-03-21 | 2023-12-31 | |
| 8-K | 2024-03-21 | — | |
| 8-K | 2024-02-08 | 2024-02-07 | |
| 8-K | 2024-01-04 | — |
Showing 1–50 of 66 filings
Key facts
CIK
1933414
CUSIP
603170101
13F (30d)
170 filings
169 filers
Visit website
Investor relations